LINC01670

Across TCGA pan-cancer cohorts, LINC01670 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01670 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01670 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01670 expression acts as an unfavorable survival marker, although some lineages such as THYM and LUSC show a favorable association.

COAD, ESCA, and UCS are the cancer types where LINC01670 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	II,III,IV	0.535	0.691	.006	51	view →
ESCA	OS	Quartile	III,IV	0.326	0.617	.005	44	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
KIRC	DFS	Tertile	IV	0.315	0.641	.014	30	view →
STAD	OS	Quartile	III,IV	0.204	0.596	.001	18	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
KIRP	OS	Tertile	IV	0.099	0.463	.001	18	view →
THCA	OS	Tertile	IV	0.406	0.871	<.001	15	view →
LUAD	DFS	Tertile	IV	0.671	0.893	.019	12	view →
CESC	OS	Quartile	IV	0.266	0.641	.011	12	view →
CHOL	DFS	Quartile	All	0.147	0.528	.030	6	view →
THYM	DFS	Tertile	All	0.970	0.825	.016	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01670–COAD (DFS)

Open the COAD breakdown →